N-[3-(3-CARBOXAMIDOPYRAZOLO-[1.5-A]-PYRIMIDIN-7-YL)-PHENYL]-N-ETHYLACETAMIDE;IMPURITY_II;ZALEPLON-CARBOXAMIDE
Compound with spectra: 1 NMR
![N-[3-(3-CARBOXAMIDOPYRAZOLO-[1.5-A]-PYRIMIDIN-7-YL)-PHENYL]-N-ETHYLACETAMIDE;IMPURITY_II;ZALEPLON-CARBOXAMIDE](/api/compound/90OH7zYwfzS.png?ph=true&h=300&w=458 "N-[3-(3-CARBOXAMIDOPYRAZOLO-[1.5-A]-PYRIMIDIN-7-YL)-PHENYL]-N-ETHYLACETAMIDE;IMPURITY_II;ZALEPLON-CARBOXAMIDE")
| SpectraBase Compound ID | 90OH7zYwfzS |
|---|---|
| InChI | InChI=1S/C17H17N5O2/c1-3-21(11(2)23)13-6-4-5-12(9-13)15-7-8-19-17-14(16(18)24)10-20-22(15)17/h4-10H,3H2,1-2H3,(H2,18,24) |
| InChIKey | LWJNCPLYHQLZAN-UHFFFAOYSA-N |
| Mol Weight | 323.36 g/mol |
| Molecular Formula | C17H17N5O2 |
| Exact Mass | 323.138225 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
2-Anilino-7-methyl-N-(4-methylphenyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide-
2-Anilino-7-methyl-N-(4-chlorophenyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide-
2-Anilino-7-methyl-N-phenylpyrazolo[1,5-a]pyrimidine-3-carboxamide
2-[(E)-2-(4-Hydroxyphenyl)ethenyl]-3-(3-methoxyphenyl)-4(3H)-quinazolinone
1,6-Dimethyl-5-(2-tolyl)-pyrazolo(3,4-D)pyrimidin-4(5H)-one
(5Z)-5-[3-bromo-4-[2-(3,4-dimethylphenoxy)ethoxy]-5-methoxy-benzylidene]-1-(m-tolyl)barbituric acid
N-(3,4-dimethylphenyl)-N-[(2-hydroxy-3-quinolinyl)methyl]-3,4,5-trimethoxybenzamide
2-[2-(4-dimethylamino-phenyl)-vinyl]-3-(3-methoxy-phenyl)-3H-quinazolin-4-one
HDVXMNIFIBHMTJ-UHFFFAOYSA-N
1H-isoindole-1,3(2H)-dione, 2-[3-(3,4-dimethylbenzoyl)phenyl]-5-nitro-
| Title | Journal or Book | Year |
|---|---|---|
| Impurity profile study of zaleplon | Journal of Pharmaceutical and Biomedical Analysis | 2007 |